| Literature DB >> 29581673 |
Kunihiko Anami1,2, Jun Horie3, Yoshiyasu Hirayama4, Naoki Yamashita5, Kenichi Ito6.
Abstract
[Purpose] The associations between changes in respiratory function, exercise tolerance, and quality of life (QOL) in patients with lung cancer who undergo lobectomy using video-assisted thoracoscopic surgery (VATS) are unclear. This study aimed to investigate the relationships between exercise tolerance and QOL in patients who underwent VATS.Entities:
Keywords: Exercise tolerance; Quality of life; Video-assisted thoracic surgery
Year: 2018 PMID: 29581673 PMCID: PMC5857460 DOI: 10.1589/jpts.30.467
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Characteristics of participants (n=36)
| Mean ± SD or n (%) | ||
|---|---|---|
| Age (years) | 73.2 ± 6.7 | |
| Gender, Male (n) | 22 (61.1) | |
| Body mass index | 23.9 ± 3.1 | |
| Duration of hospital stay (days) | 10.4 ± 2.7 | |
| Lesion location (n) | ||
| LUL | 5 (13.9) | |
| LLL | 6 (16.7) | |
| RUL | 11 (30.5) | |
| RML | 4 (11.1) | |
| RLL | 10 (27.8) | |
| Extent of surgery | ||
| Segmentectomy | 11 (30.5) | |
| Lobectomy | 25 (69.5) | |
| TNM stage (n) | ||
| T1a/T1b/T2a/T2aN1/T2b | 17/5/8/2/1 | |
| Primary Tumor (n) | 34 (94.4) | |
| Comorbidity (n) | ||
| COPD | 10 (27.8) | |
| Diabetes | 6 (16.7) | |
| Hypertension | 9 (25.0) | |
| Postoperative pain (n) | 6 (16.7) | |
LUL: left upper lobectomy; RUL: right upper lobectomy; RML: right midle lobectomy; LLL: left lower lobectomy; RLL: right lower lobectomy; TNM: tumor-nodal-metastasis; COPD: chronic obstructive pulmonary disease; SD: standard deviation.
Chronological changes in physical function (n=36)
| Baseline | 1 week | 4 weeks | 12 weeks | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| Respiratory function | |||||
| FVC (l) | 2.79 ± 0.63 | 2.27 ± 0.52* | 2.39 ± 0.52* | ||
| %FVC (% predicted) | 98.0 ± 15.0 | 79.4 ± 13.4* | 84.1 ± 13.9* | ||
| FEV1.0 (l) | 2.13 ± 0.51 | 1.77 ± 0.45* | 1.90 ± 0.48* | ||
| %FEV1.0 (% predicted) | 95.5 ± 20.2 | 78.8 ± 16.9* | 84.8 ± 17.6* | ||
| FEV1.0/FVC (%) | 76.4 ± 9.2 | 78.2 ± 10.2 | 79.3 ± 9.6 | ||
| Cardiopulmonary exercise test (AT) | |||||
| VO2 (ml/kg/min) | 12.0 ± 2.4 | 11.7 ± 2.4 | 11.7 ± 2.5 | ||
| VCO2 (ml/kg/min) | 11.4 ± 2.6 | 11.3 ± 2.5 | 11.4 ± 2.5 | ||
| Cardiopulmonary exercise test (Peak) | |||||
| VO2 (ml/kg/min) | 16.2 ± 4.2 | 15.2 ± 4.1 | 15.4 ± 4.1 | ||
| VCO2 (ml/kg/min) | 17.0 ± 5.4 | 16.4 ± 5.4 | 16.7 ± 4.9 | ||
| Muscle strength | |||||
| Hand grip (kg) | 30.5 ± 9.1 | 28.7 ± 9.3* | 29.7 ± 8.8 | 30.2 ± 9.0 | |
| Knee extension strength (% BW) | 45.9 ± 13.9 | 42.8 ± 14.1* | 49.8 ± 6.7* | 51.3 ± 18.4* | |
| Walking ability | |||||
| TUG (sec) | 6.1 ± 1.6 | 7.0 ± 2.2* | 6.3 ± 1.7 | 6.2 ± 1.8 | |
| 6MWT (m) | 523.2 ± 116.3 | 463.9 ± 112.3* | 516.5 ± 115.0 | 535.1 ± 120.2 | |
*p<0.05 vs. preoperative; FVC: forced expiratory volume; l: liter; FEV: forced expiratory volume; AT: anaerobic threshold; VO2: uptake; VCO2: carbon output; W: mechanical power; TUG: timed up and go; 6MWT: 6-minute walking distance test; SD: standard deviation.
Chronological changes as recorded on the short-form 36 health survey (SF-36) (n=36)
| Baseline | 1 week | 4 weeks | 12 weeks | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| SF-36 subscales (0–100 points) | |||||
| PF | 81.8 ± 13.6 | 66.3 ± 22.1* | 73.7 ± 21.2* | 78.0 ± 14.6 | |
| RP | 78.8 ± 24.3 | 54.0 ± 31.0* | 51.5 ± 28.4* | 70.3 ± 24.9 | |
| BP | 76.7 ± 23.4 | 63.0 ± 29.7* | 59.4 ± 27.3* | 70.8 ± 20.2 | |
| GH | 62.0 ± 17.0 | 55.5 ± 21.0 | 58.5 ± 16.3 | 60.8 ± 16.7 | |
| VT | 65.9 ± 17.8 | 60.4 ± 22.9 | 54.5 ± 25.3* | 65.0 ± 23.3 | |
| SF | 85.6 ± 16.3 | 75.8 ± 24.6 | 66.3 ± 25.9* | 79.9 ± 18.7 | |
| RE | 79.3 ± 26.1 | 63.1 ± 32.1* | 61.1 ± 34.3* | 75.0 ± 29.2 | |
| MH | 66.1 ± 18.7 | 68.3 ± 18.7 | 63.6 ± 23.6 | 72.0 ± 19.0 | |
| SF-36 subscales (Scoring method based on national standard value) | |||||
| PF | 44.7 ± 9.8 | 33.8 ± 16.1* | 38.9 ± 15.3* | 42.0 ± 10.5 | |
| RP | 44.4 ± 12.9 | 32.1 ± 16.4* | 29.9 ± 15.1* | 39.9 ± 13.2 | |
| BP | 51.3 ± 10.5 | 44.5 ± 12.9* | 43.6 ± 12.2* | 48.7 ± 9.0 | |
| GH | 49.5 ± 9.1 | 45.6 ± 10.8 | 47.6 ± 8.7 | 48.9 ± 8.9 | |
| VT | 51.6 ± 9.1 | 49.4 ± 10.7 | 45.7 ± 13.0* | 51.1 ± 12.0 | |
| SF | 49.6 ± 8.4 | 44.1 ± 12.5* | 39.6 ± 13.3* | 46.7 ± 9.7 | |
| RE | 45.7 ± 13.0 | 36.9 ± 15.7* | 36.6 ± 17.2* | 43.6 ± 14.6 | |
| MH | 47.0 ± 10.0 | 47.3 ± 10.1 | 45.7 ± 12.6 | 50.2 ± 10.2 | |
| SF-36 component summary score | |||||
| PCS | 47.1 ± 11.2 | 35.9 ± 15.0* | 41.6 ± 12.8* | 43.2 ± 10.3* | |
| MCS | 52.7 ± 9.6 | 56.1 ± 8.5 | 53.5 ± 9.4 | 55.2 ± 8.8 | |
| RCS | 45.0 ± 13.6 | 36.8 ± 13.7* | 32.6 ± 14.8* | 42.0 ± 13.5 | |
*p<0.05 vs. preoperative; PF: physical functioning; RP: physical role functioning; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: emotional role functioning; MH: mental health; PCS: physical component summary; MCS: mental component summary; RCS: role/social component summary; SD: standard deviation.
Relationship between physical function and health-related QOL in preoperative (n=36)
| PCS | MCS | RCS | ||
|---|---|---|---|---|
| Respiratory function | ||||
| %FVC | –0.17 | 0.02 | –0.14 | |
| %FEV1.0 | –0.16 | 0.02 | –0.13 | |
| Cardiopulmonary exercise test (AT) | ||||
| VO2 | 0.10 | 0.14 | –0.04 | |
| VCO2 | 0.04 | 0.03 | 0.01 | |
| Cardiopulmonary exercise test (Peak) | ||||
| VO2 | 0.23 | 0.03 | 0.10 | |
| VCO2 | 0.20 | –0.04 | 0.12 | |
| Muscle strength | ||||
| Hand grip | 0.40* | –0.05 | –0.09 | |
| Knee extension strength | 0.44* | –0.08 | 0.06 | |
| Walking ability | ||||
| TUG | –0.59* | 0.17 | –0.14 | |
| 6MWT | 0.56* | –0.13 | 0.14 | |
*p<0.05; QOL: quality of life; FVC: forced expiratory volume; FEV1.0: forced expiratory volume; VO2: uptake; VCO2: carbon dioxideoutput; W: mechanical power; TUG: timed up and go; 6MWT: 6-minute walking distance test; PCS: physical component summary; MCS: mental component summary; RCS: role/social component summary.
Relationship between rate of change in physical function and rate of change in QOL from preoperative to postoperative 12 weeks (n=36)
| PCS | MCS | RCS | ||
|---|---|---|---|---|
| Respiratory function | ||||
| %FVC | 0.09 | 0.01 | –0.28 | |
| %FEV1.0 | 0.03 | –0.07 | –0.12 | |
| Cardiopulmonary exercise test (AT) | ||||
| VO2 | –0.12 | 0.27 | –0.02 | |
| VCO2 | –0.13 | 0.15 | –0.18 | |
| Cardiopulmonary exercise test (Peak) | ||||
| VO2 | 0.05 | 0.17 | 0.01 | |
| VCO2 | –0.11 | 0.23 | –0.05 | |
| Muscle strength | ||||
| Hand grip | 0.18 | 0.01 | 0.18 | |
| Knee extension strength | 0.08 | –0.11 | 0.02 | |
| Walking ability | ||||
| TUG | 0.07 | 0.16 | –0.24 | |
| 6MWT | 0.07 | –0.10 | 0.09 | |
*p<0.05; QOL: quality of life; FVC: forced expiratory volume; FEV1.0: forced expiratory volume; VO2: uptake; VCO2: carbon dioxide output; W: mechanical power; TUG: timed up and go; 6MWT: 6-minute walking distance test; PCS: physical component summary; MCS: mental component summary; RCS: role/social component summary.